BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 20736855)

  • 41. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
    Otsuka S; Klimowicz AC; Kopciuk K; Petrillo SK; Konno M; Hao D; Muzik H; Stolte E; Boland W; Morris D; Magliocco AM; Bebb DG
    J Thorac Oncol; 2011 Jul; 6(7):1169-78. PubMed ID: 21623238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics.
    Sterlacci W; Tzankov A; Veits L; Oberaigner W; Schmid T; Hilbe W; Fiegl M
    Am J Clin Pathol; 2011 Apr; 135(4):611-8. PubMed ID: 21411784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer.
    Shimizu K; Okita R; Saisho S; Maeda A; Nojima Y; Nakata M
    World J Surg Oncol; 2015 Sep; 13():291. PubMed ID: 26424708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical Resection.
    Kastelijn EA; El Sharouni SY; Hofman FN; Van Putte BP; Monninkhof EM; Van Vulpen M; Schramel FM
    Anticancer Res; 2015 Oct; 35(10):5607-14. PubMed ID: 26408733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: the Japanese Lung Cancer Registry Study 2004.
    Inoue M; Okumura M; Sawabata N; Miyaoka E; Asamura H; Yoshino I; Tada H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Kobayashi H; Yokoi K
    Lung Cancer; 2014 Feb; 83(2):246-51. PubMed ID: 24296124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic stratification of patients with T3N1M0 non-small cell lung cancer: which phase should it be?
    Kilicgun A; Tanriverdi O; Turna A; Metin M; Sayar A; Solak O; Urer N; Gurses A
    Med Oncol; 2012 Jun; 29(2):607-13. PubMed ID: 21431959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.
    Warwick R; Mediratta N; Shackcloth M; Page R; McShane J; Shaw M; Poullis M
    Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):566-73. PubMed ID: 24570559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland.
    Thorsteinsson H; Alexandersson A; Oskarsdottir GN; Skuladottir R; Isaksson HJ; Jonsson S; Gudbjartsson T
    J Thorac Oncol; 2012 Jul; 7(7):1164-9. PubMed ID: 22592213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sarcoidal reactions in regional lymph nodes of patients with early stage non-small cell lung cancer predict improved disease-free survival: a pilot case-control study.
    Steinfort DP; Tsui A; Grieve J; Hibbs ML; Anderson GP; Irving LB
    Hum Pathol; 2012 Mar; 43(3):333-8. PubMed ID: 21835432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer.
    Dhillon T; Mauri FA; Bellezza G; Cagini L; Barbareschi M; North BV; Seckl MJ
    J Thorac Oncol; 2010 Mar; 5(3):314-9. PubMed ID: 20093977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases.
    Maeda H; Matsumura A; Kawabata T; Suito T; Kawashima O; Watanabe T; Okabayashi K; Kubota I;
    Eur J Cardiothorac Surg; 2012 Feb; 41(2):357-61. PubMed ID: 21737295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.
    Matsuo Y; Shibuya K; Nagata Y; Takayama K; Norihisa Y; Mizowaki T; Narabayashi M; Sakanaka K; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1104-11. PubMed ID: 20472343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancers.
    Tanvetyanon T; Robinson L; Sommers KE; Haura E; Kim J; Altiok S; Bepler G
    J Thorac Oncol; 2010 Jul; 5(7):1018-24. PubMed ID: 20453687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Chou TY; Huang BS; Wu YC
    J Thorac Oncol; 2012 Jul; 7(7):1115-23. PubMed ID: 22592210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival of M1a Non-Small Cell Lung Cancer Treated Surgically: A Retrospective Single-Center Study.
    Liu T; Liu H; Wang G; Zhang C; Liu B
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):577-82. PubMed ID: 25893920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of blood group antigen A by stage I non-small cell lung carcinomas.
    Rice TW; Tubbs RR; Hoeltge GA; Kirby TJ; Meeker DP; Medendorp SV; Bukowski RM
    Ann Thorac Surg; 1995 Mar; 59(3):568-72. PubMed ID: 7887691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
    Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
    J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Completion pneumonectomy in patients with cancer: postoperative survival and mortality factors.
    Tabutin M; Couraud S; Guibert B; Mulsant P; Souquet PJ; Tronc F
    J Thorac Oncol; 2012 Oct; 7(10):1556-62. PubMed ID: 22982656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.